| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |